| Audencel immunotherapy based on dendritic cells has no effect on overall and progression-free survival in newly diagnosed glioblastoma: a phase II randomized trial J Buchroithner, F Erhart, J Pichler, G Widhalm, M Preusser, ... Cancers 10 (10), 372, 2018 | 79 | 2018 |
| Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related … F Erhart, J Buchroithner, R Reitermaier, K Fischhuber, S Klingenbrunner, ... Acta neuropathologica communications 6, 1-14, 2018 | 47 | 2018 |
| Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung … J Gratz, A Pausch, E Schaden, A Baierl, P Jaksch, F Erhart, ... Artificial organs 44 (6), 638-646, 2020 | 34 | 2020 |
| Gliomasphere marker combinatorics: Multidimensional flow cytometry detects CD 44+/CD 133+/ITGA 6+/CD 36+ signature F Erhart, B Blauensteiner, G Zirkovits, D Printz, K Soukup, ... Journal of cellular and molecular medicine 23 (1), 281-292, 2019 | 29 | 2019 |
| IFN-γ and tumor gangliosides: Implications for the tumor microenvironment B Dillinger, S Ahmadi-Erber, M Lau, MA Hoelzl, F Erhart, B Juergens, ... Cellular immunology 325, 33-40, 2018 | 22 | 2018 |
| Illness perception in primary cutaneous t-cell lymphomas: what patients believe about their disease. J Eder, M Kammerstätter, F Erhart, D Mairhofer-Muri, F Trautinger Acta Dermato-Venereologica 96 (3), 2016 | 20 | 2016 |
| Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors F Erhart, M Hackl, H Hahne, J Buchroithner, C Meng, S Klingenbrunner, ... npj Vaccines 5 (1), 5, 2020 | 18 | 2020 |
| Mast cells are abundant in primary cutaneous T-cell lymphomas: results from a computer-aided quantitative immunohistological study J Eder, R Rogojanu, W Jerney, F Erhart, A Dohnal, M Kitzwögerer, ... PLoS One 11 (11), e0163661, 2016 | 17 | 2016 |
| TCGA mRNA expression analysis of the heme biosynthesis pathway in diffusely infiltrating gliomas: a comparison of typically 5-ALA fluorescent and non-fluorescent gliomas M Mischkulnig, B Kiesel, D Lötsch, T Roetzer, M Borkovec, LI Wadiura, ... Cancers 12 (8), 2043, 2020 | 12 | 2020 |
| Fibroblast growth factor receptor 4 promotes glioblastoma progression: A central role of integrin-mediated cell invasiveness L Gabler, CN Jaunecker, S Katz, S van Schoonhoven, B Englinger, ... Acta Neuropathologica Communications 10 (1), 65, 2022 | 10 | 2022 |
| MRI response assessment in glioblastoma patients treated with dendritic-cell-based immunotherapy J Heugenhauser, M Galijasevic, S Mangesius, G Goebel, J Buchroithner, ... Cancers 14 (6), 1579, 2022 | 8 | 2022 |
| Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic … F Erhart, T Weiss, S Klingenbrunner, K Fischhuber, R Reitermaier, ... Cytotherapy 21 (6), 643-658, 2019 | 8 | 2019 |
| Heme biosynthesis mRNA expression signature: towards a novel prognostic biomarker in patients with diffusely infiltrating gliomas M Mischkulnig, B Kiesel, D Lötsch, T Roetzer, M Borkovec, LI Wadiura, ... Cancers 13 (4), 662, 2021 | 6 | 2021 |
| Precision medicine for the management of therapy refractory colorectal cancer H Taghizadeh, RM Mader, L Müllauer, F Erhart, A Kautzky-Willer, ... Journal of Personalized Medicine 10 (4), 272, 2020 | 5 | 2020 |
| Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts C Sturtzel, S Grissenberger, P Bozatzi, E Scheuringer, ... NPJ precision oncology 7 (1), 44, 2023 | 3 | 2023 |
| The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers M Mischkulnig, B Kiesel, T Rötzer-Pejrimovsky, M Borkovec, A Lang, ... Frontiers in Molecular Neuroscience 15, 928355, 2022 | 3 | 2022 |
| Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis A Lang, RL Jeron, B Lontzek, B Kiesel, M Mischkulnig, AS Berghoff, ... Journal of Neuro-oncology 164 (1), 211-220, 2023 | 2 | 2023 |
| Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization M Mischkulnig, V Sperl, F Erhart, B Kiesel, A Lang, A Hosmann, T Roetzer, ... Photodiagnosis and Photodynamic Therapy 38, 102755, 2022 | 1 | 2022 |
| Potential of immune biomarkers for predicting survival in glioblastoma patients receiving dendritic cell cancer immunotherapy (VAC12P. 1012) C Visus, K Fischhuber, S Klingenbrunner, R Reitermaier, H Knausz, ... The Journal of Immunology 192 (1_Supplement), 206.1-206.1, 2014 | 1 | 2014 |
| The plasma miRNome and venous thromboembolism in high‐grade glioma: miRNA Sequencing of a nested case–control cohort F Erhart, G Widhalm, B Kiesel, M Hackl, A Diendorfer, M Preusser, ... Journal of Cellular and Molecular Medicine 28 (8), e18149, 2024 | | 2024 |
